danio vision observation chamber dvoc Search Results


danio vision observation chamber dvoc  (Noldus Information Technology)
86
Noldus Information Technology danio vision observation chamber dvoc
Danio Vision Observation Chamber Dvoc, supplied by Noldus Information Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/chamber+daniovision+observation/bio_rxiv__64898__2026__02__03__703464-81-16-10
Average 86 stars, based on 1 article reviews
danio vision observation chamber dvoc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
daniovision model dvoc 0030  (Noldus Information Technology)
86
Noldus Information Technology daniovision model dvoc 0030
Daniovision Model Dvoc 0030, supplied by Noldus Information Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/0030+daniovision+dvoc+model/pmc10953468-239-7-16
Average 86 stars, based on 1 article reviews
daniovision model dvoc 0030 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
dvot  (Bachem)
90
Bachem dvot
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvot, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvot/pmc07538669-33-3-7
Average 90 stars, based on 1 article reviews
dvot - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hot air oven j-dvo1  (Jisico Co Ltd)
90
Jisico Co Ltd hot air oven j-dvo1
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Hot Air Oven J Dvo1, supplied by Jisico Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/vacuum+oven+j+dvo1/10__1016_slash_j__rineng__2024__101910-105-24-26
Average 90 stars, based on 1 article reviews
hot air oven j-dvo1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dvd recorder dvo 1000md  (Sony)
90
Sony dvd recorder dvo 1000md
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvd Recorder Dvo 1000md, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvd+recorder+dvo+1000md/pmc05958146-97-28-27
Average 90 stars, based on 1 article reviews
dvd recorder dvo 1000md - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dvd recorder  (Sony)
90
Sony dvd recorder
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvd Recorder, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvd+recorder/10__1161_slash_hypertensionaha__114__04662-230-10-9
Average 90 stars, based on 1 article reviews
dvd recorder - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dvo büro  (Georg Thieme Verlag KG)
90
Georg Thieme Verlag KG dvo büro
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvo Büro, supplied by Georg Thieme Verlag KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvo+b%C3%BCro/10__1055_slash_s___0038___1673551-2-8-1
Average 90 stars, based on 1 article reviews
dvo büro - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dvo leitlinie 2017  (Georg Thieme Verlag KG)
90
Georg Thieme Verlag KG dvo leitlinie 2017
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvo Leitlinie 2017, supplied by Georg Thieme Verlag KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvo+leitlinie+2017/10__1055_slash_s___0038___1673537-20-0-65
Average 90 stars, based on 1 article reviews
dvo leitlinie 2017 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
behavior recording system  (Noldus Information Technology)
86
Noldus Information Technology behavior recording system
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Behavior Recording System, supplied by Noldus Information Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/behavior+ethovision+recognition+system+video+xt/pm41045584-65-11-18
Average 86 stars, based on 1 article reviews
behavior recording system - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
dvo 2  (LifePort Inc)
90
LifePort Inc dvo 2
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Dvo 2, supplied by LifePort Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/dvo+2/pmc03810436-131-17-14
Average 90 stars, based on 1 article reviews
dvo 2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
quantikine® vegf dvoo elisa  (DPC Biermann GmbH)
90
DPC Biermann GmbH quantikine® vegf dvoo elisa
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Quantikine® Vegf Dvoo Elisa, supplied by DPC Biermann GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/quantikine++vegf+dvoo+elisa/pm09512224-35-10-14
Average 90 stars, based on 1 article reviews
quantikine® vegf dvoo elisa - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
oncologické centrum  (Klinika Medical GmbH)
90
Klinika Medical GmbH oncologické centrum
Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor <t>agonist,</t> <t>TGOT</t> (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and <t>dVOT</t> (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.
Oncologické Centrum, supplied by Klinika Medical GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/danio+vision+observation+chamber+dvoc/oncologick%C3%A9+centrum/pm25312714-51-0-13
Average 90 stars, based on 1 article reviews
oncologické centrum - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor agonist, TGOT (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and dVOT (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.

Journal: Frontiers in Neuroscience

Article Title: Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System

doi: 10.3389/fnins.2020.581977

Figure Lengend Snippet: Intrathecal OT induced hindpaw scratching behavior was mediated by spinal OTRs. (A) Time course of different doses of intrathecal OT evoked scratching bouts in mice. OT at dose of 0.003, 0.01, 0.03, 0.1, and 0.3 nmol was administered intrathecally, scratching bouts of the mice were then recorded every 5 min for 30 min. (B) Different doses of intrathecal OT-induced scratching bouts in 30 min after injection. Data are expressed as mean ± SEM. ** p < 0.01, **** p < 0.0001 vs. Saline; One-way ANOVA followed by Bonferroni’s post hoc test. (C) Dose-response curve of intrathecal OT-induced scratching behaviors. (D) Intrathecal OT-induced itch behavior in male and female mice. OT at dose of 0.03 nmol was administered intrathecally, scratching bouts was then recorded for 30 min. Data are expressed as mean ± SEM paired T - test. (E) Intrathecal administration of a selective OT receptor agonist, TGOT (0.03 nmol) caused scratching behaviors similar to OT in mice. (F) Intrathecal administration of selective V1aR antagonist, also a selective OT receptor agonist, TC OT 39 (0.1 nmol) caused significant scratching behaviors in mice. (G) Intrathecal administration of selective OT receptor antagonists, Atosiban (0.1 nmol) and dVOT (0.1 nmol) decreased OT induced scratching behaviors in mice. (H) Selective blockade of V1aR by pretreatment of its antagonist, RG7314 (0.1 nmol) did not prevent OT-induced scratching behaviors in mice. I Morphine (0.3 nmol, i.t.) had no effect on OT-induced scratching. Data are expressed as mean ± SEM paired T - test. * p < 0.05.

Article Snippet: Oxytocin, TGOT, and dVOT were purchased from Bachem AG (Bubendorf, Switzerland).

Techniques: Injection, Saline